Selecting the Components for a Safe and Efficient Tuberculosis Subunit Vaccine - Recent Progress and Post-Genomic Insights

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|4|1|69-83

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.4, Iss.1, 2003-02, pp. : 69-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging therapeutic targets in tuberculosis: post-genomic era

By Khasnobis Shampa   Escuyer Vincent E   Chatterjee Delphi  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 1, 2002-02 ,pp. : 21-40

Informa Healthcare

Access to resources Recommend Favorite

Familial Mediterranean Fever in the Post-Genomic Era: How an Ancient Disease is Providing New Insights into Inflammatory Pathways

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 1, 2005-02 ,pp. : 67-76

Bentham Science Publishers

Access to resources Recommend Favorite

Recent progress in tumour vaccine development

By Le Poole I Caroline   Bommiasamy Hemamalini   Kast W Martin  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 6, 2003-06 ,pp. : 971-981

Informa Healthcare

Access to resources Recommend Favorite

Post-Genomic Design of Bioactive Molecules

By  

Current Computer - Aided Drug Design, Vol. 1, Iss. 2, 2005-04 ,pp. : 147-162

Bentham Science Publishers

Access to resources Recommend Favorite

Mycobacterium tuberculosis Treatment Modalities and Recent Insights

By  

Current Drug Delivery, Vol. 11, Iss. 6, 2014-12 ,pp. : 744-752

Bentham Science Publishers

Access to resources Recommend Favorite